Click for best price
Recombinant Coagulation Factor IX Market Size, Share 2022
This report contains market size and forecasts of Recombinant Coagulation Factor IX in global, including the following market information:
Global Recombinant Coagulation Factor IX Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Coagulation Factor IX Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Coagulation Factor IX companies in 2021 (%)
The global Recombinant Coagulation Factor IX market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
500 IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Coagulation Factor IX include Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Coagulation Factor IX manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Coagulation Factor IX Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Type, 2021 (%)
500 IU
1000 IU
Other
Global Recombinant Coagulation Factor IX Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, by Application, 2021 (%)
Adult
Children
Global Recombinant Coagulation Factor IX Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor IX Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Coagulation Factor IX revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Coagulation Factor IX revenues share in global market, 2021 (%)
Key companies Recombinant Coagulation Factor IX sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Coagulation Factor IX sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Rebinyn
CSL Behring
Takeda
Sanofi
Aptevo Bio Therapeutics
Thermo Fisher
| Report Attributes |
Report Details |
| Report Title |
Recombinant Coagulation Factor IX Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Coagulation Factor IX Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Coagulation Factor IX Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Coagulation Factor IX Overall Market Size
2.1 Global Recombinant Coagulation Factor IX Market Size: 2021 VS 2028
2.2 Global Recombinant Coagulation Factor IX Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Coagulation Factor IX Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Coagulation Factor IX Players in Global Market
3.2 Top Global Recombinant Coagulation Factor IX Companies Ranked by Revenue
3.3 Global Recombinant Coagulation Factor IX Revenue by Companies
3.4 Global Recombinant Coagulation Factor IX Sales by Companies
3.5 Global Recombinant Coagulation Factor IX Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Coagulation Factor IX Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Coagulation Factor IX Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Coagulation Factor IX Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Coagulation Factor IX Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor IX Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Coagulation Factor IX Market Size Markets, 2021 & 2028
4.1.2 500 IU
4.1.3 1000 IU
4.1.4 Other
4.2 By Type - Global Recombinant Coagulation Factor IX Revenue & Forecasts
4.2.1 By Type - Global Recombinant Coagulation Factor IX Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Coagulation Factor IX Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Coagulation Factor IX Sales & Forecasts
4.3.1 By Type - Global Recombinant Coagulation Factor IX Sales, 2017-2022
4.3.2 By Type - Global Recombinant Coagulation Factor IX Sales, 2023-2028
4.3.3 By Type - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Coagulation Factor IX Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Coagulation Factor IX Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Children
5.2 By Application - Global Recombinant Coagulation Factor IX Revenue & Forecasts
5.2.1 By Application - Global Recombinant Coagulation Factor IX Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Coagulation Factor IX Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Coagulation Factor IX Sales & Forecasts
5.3.1 By Application - Global Recombinant Coagulation Factor IX Sales, 2017-2022
5.3.2 By Application - Global Recombinant Coagulation Factor IX Sales, 2023-2028
5.3.3 By Application - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Coagulation Factor IX Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Coagulation Factor IX Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Coagulation Factor IX Revenue & Forecasts
6.2.1 By Region - Global Recombinant Coagulation Factor IX Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Coagulation Factor IX Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Coagulation Factor IX Sales & Forecasts
6.3.1 By Region - Global Recombinant Coagulation Factor IX Sales, 2017-2022
6.3.2 By Region - Global Recombinant Coagulation Factor IX Sales, 2023-2028
6.3.3 By Region - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Coagulation Factor IX Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Coagulation Factor IX Sales, 2017-2028
6.4.3 US Recombinant Coagulation Factor IX Market Size, 2017-2028
6.4.4 Canada Recombinant Coagulation Factor IX Market Size, 2017-2028
6.4.5 Mexico Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Coagulation Factor IX Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Coagulation Factor IX Sales, 2017-2028
6.5.3 Germany Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.4 France Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.5 U.K. Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.6 Italy Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.7 Russia Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Coagulation Factor IX Market Size, 2017-2028
6.5.9 Benelux Recombinant Coagulation Factor IX Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Coagulation Factor IX Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Coagulation Factor IX Sales, 2017-2028
6.6.3 China Recombinant Coagulation Factor IX Market Size, 2017-2028
6.6.4 Japan Recombinant Coagulation Factor IX Market Size, 2017-2028
6.6.5 South Korea Recombinant Coagulation Factor IX Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Coagulation Factor IX Market Size, 2017-2028
6.6.7 India Recombinant Coagulation Factor IX Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Coagulation Factor IX Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Coagulation Factor IX Sales, 2017-2028
6.7.3 Brazil Recombinant Coagulation Factor IX Market Size, 2017-2028
6.7.4 Argentina Recombinant Coagulation Factor IX Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales, 2017-2028
6.8.3 Turkey Recombinant Coagulation Factor IX Market Size, 2017-2028
6.8.4 Israel Recombinant Coagulation Factor IX Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Coagulation Factor IX Market Size, 2017-2028
6.8.6 UAE Recombinant Coagulation Factor IX Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Recombinant Coagulation Factor IX Major Product Offerings
7.1.4 Pfizer Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Rebinyn
7.2.1 Rebinyn Corporate Summary
7.2.2 Rebinyn Business Overview
7.2.3 Rebinyn Recombinant Coagulation Factor IX Major Product Offerings
7.2.4 Rebinyn Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.2.5 Rebinyn Key News
7.3 CSL Behring
7.3.1 CSL Behring Corporate Summary
7.3.2 CSL Behring Business Overview
7.3.3 CSL Behring Recombinant Coagulation Factor IX Major Product Offerings
7.3.4 CSL Behring Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.3.5 CSL Behring Key News
7.4 Takeda
7.4.1 Takeda Corporate Summary
7.4.2 Takeda Business Overview
7.4.3 Takeda Recombinant Coagulation Factor IX Major Product Offerings
7.4.4 Takeda Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.4.5 Takeda Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Recombinant Coagulation Factor IX Major Product Offerings
7.5.4 Sanofi Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Aptevo Bio Therapeutics
7.6.1 Aptevo Bio Therapeutics Corporate Summary
7.6.2 Aptevo Bio Therapeutics Business Overview
7.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Major Product Offerings
7.6.4 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.6.5 Aptevo Bio Therapeutics Key News
7.7 Thermo Fisher
7.7.1 Thermo Fisher Corporate Summary
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher Recombinant Coagulation Factor IX Major Product Offerings
7.7.4 Thermo Fisher Recombinant Coagulation Factor IX Sales and Revenue in Global (2017-2022)
7.7.5 Thermo Fisher Key News
8 Global Recombinant Coagulation Factor IX Production Capacity, Analysis
8.1 Global Recombinant Coagulation Factor IX Production Capacity, 2017-2028
8.2 Recombinant Coagulation Factor IX Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Coagulation Factor IX Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Coagulation Factor IX Supply Chain Analysis
10.1 Recombinant Coagulation Factor IX Industry Value Chain
10.2 Recombinant Coagulation Factor IX Upstream Market
10.3 Recombinant Coagulation Factor IX Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Coagulation Factor IX Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Coagulation Factor IX in Global Market
Table 2. Top Recombinant Coagulation Factor IX Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Coagulation Factor IX Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Coagulation Factor IX Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Coagulation Factor IX Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Coagulation Factor IX Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Coagulation Factor IX Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Coagulation Factor IX Product Type
Table 9. List of Global Tier 1 Recombinant Coagulation Factor IX Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor IX Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Coagulation Factor IX Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant Coagulation Factor IX Sales (K Units), 2023-2028
Table 16. By Application ? Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Coagulation Factor IX Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Coagulation Factor IX Sales (K Units), 2023-2028
Table 21. By Region ? Global Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Coagulation Factor IX Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Coagulation Factor IX Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Coagulation Factor IX Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Coagulation Factor IX Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Coagulation Factor IX Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Coagulation Factor IX Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Coagulation Factor IX Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Coagulation Factor IX Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Coagulation Factor IX Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Coagulation Factor IX Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Coagulation Factor IX Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Recombinant Coagulation Factor IX Product Offerings
Table 48. Pfizer Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Rebinyn Corporate Summary
Table 50. Rebinyn Recombinant Coagulation Factor IX Product Offerings
Table 51. Rebinyn Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. CSL Behring Corporate Summary
Table 53. CSL Behring Recombinant Coagulation Factor IX Product Offerings
Table 54. CSL Behring Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Takeda Corporate Summary
Table 56. Takeda Recombinant Coagulation Factor IX Product Offerings
Table 57. Takeda Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi Recombinant Coagulation Factor IX Product Offerings
Table 60. Sanofi Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Aptevo Bio Therapeutics Corporate Summary
Table 62. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Offerings
Table 63. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Thermo Fisher Corporate Summary
Table 65. Thermo Fisher Recombinant Coagulation Factor IX Product Offerings
Table 66. Thermo Fisher Recombinant Coagulation Factor IX Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Recombinant Coagulation Factor IX Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Recombinant Coagulation Factor IX Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Recombinant Coagulation Factor IX Production by Region, 2017-2022 (K Units)
Table 70. Global Recombinant Coagulation Factor IX Production by Region, 2023-2028 (K Units)
Table 71. Recombinant Coagulation Factor IX Market Opportunities & Trends in Global Market
Table 72. Recombinant Coagulation Factor IX Market Drivers in Global Market
Table 73. Recombinant Coagulation Factor IX Market Restraints in Global Market
Table 74. Recombinant Coagulation Factor IX Raw Materials
Table 75. Recombinant Coagulation Factor IX Raw Materials Suppliers in Global Market
Table 76. Typical Recombinant Coagulation Factor IX Downstream
Table 77. Recombinant Coagulation Factor IX Downstream Clients in Global Market
Table 78. Recombinant Coagulation Factor IX Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Coagulation Factor IX Segment by Type
Figure 2. Recombinant Coagulation Factor IX Segment by Application
Figure 3. Global Recombinant Coagulation Factor IX Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Coagulation Factor IX Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Coagulation Factor IX Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Coagulation Factor IX Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Coagulation Factor IX Revenue in 2021
Figure 9. By Type - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Coagulation Factor IX Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Coagulation Factor IX Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 19. US Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 33. China Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Coagulation Factor IX Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Coagulation Factor IX Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Coagulation Factor IX by Region, 2021 VS 2028
Figure 50. Recombinant Coagulation Factor IX Industry Value Chain
Figure 51. Marketing Channels
